The aim of our current study was therefore to determine the expression levels of the CRBN-binding proteins IKZF1, IKZF3, and KPNA2 in MM cells by flow cytometry and to assess correlations of their expression levels with clinical and prognostic factors measured at the time of diagnosis in a large patient cohort. This evidence concerns the gene KPNA2 and Miyoshi myopathy.